Not applicableLooking for participantsNCT06503224
What this trial is testing
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
Who this might be right for
Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China 18